Evidence map›Paper›PMID 30113213›Full record

ArticleFuture microbiology2018

SDH2 is involved in proper hypha formation and virulence in Candida albicans.

Shuang Bi, Quan-Zhen Lv, Tian-Tian Wang, Beth Burgwyn Fuchs, Dan-Dan Hu, Cleo G Anastassopoulou, Athanasios Desalermos, Maged Muhammed, Chin-Lee Wu, Yuan-Ying Jiang and 2 more

Abstract read
In one paragraph

Article in Future microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Unveiling the roles ofVirulence · 2024
    Article
  4. Review
  5. Article
  6. Evaluation of Anti-Journal of fungi (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Transcriptional Control of Hypoxic Hyphal Growth in the Fungal PathogenFrontiers in cellular and infection microbiology · 2021
    Article
  9. Frontiers in cellular and infection microbiology · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Shuang BiSchool of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
Quan-Zhen LvSchool of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
Tian-Tian WangSchool of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
Beth Burgwyn FuchsDivision of Infectious Diseases, Rhode Island Hospital, Alpert Medical School of Brown University, RI 02903, USA.
Dan-Dan HuSchool of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
Cleo G AnastassopoulouDivision of Genetics, Cell & Developmental Biology, Department of Biology, University of Patras, Patras, Greece.
Athanasios DesalermosDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Maged MuhammedDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Chin-Lee WuDepartment of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Yuan-Ying JiangSchool of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
Eleftherios MylonakisDivision of Infectious Diseases, Rhode Island Hospital, Alpert Medical School of Brown University, RI 02903, USA.
Yan WangSchool of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
Second Military Medical University · CNMassachusetts General Hospital · USGTx (United States) · USHarvard University · USNewton Wellesley Hospital · USRhode Island Hospital · USUniversity of Patras · GR

Funding

A C.elegans high-throughput assay for the identification of new antifungal agentsR01AI075286 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MYLONAKIS, ELEFTHERIOS · 2008 to 2010
$1.3M
NIAID NIH HHS R01 AI075286
6 · The paper itself

Abstract

aimTo investigate the role of SDH2 in Candida albicans filamentation and virulence. MATERIALS &

methodsCaenorhabditis elegans and mouse candidiasis models were used to assess the virulence of a sdh2Δ/Δ mutant. Various hypha-inducing media were used to evaluate the hyphal development of C. albicans. DCFH-DA was used to measure intracellular Reactive Oxygen Species (ROS) levels.

resultsThe sdh2Δ/Δ mutant was avirulent in the C. elegans model, hypovirulent in a murine candidiasis model, and defective to form filaments both in vitro and in vivo. Intracellular ROS level increased in the sdh2Δ/Δ mutant, and the filamentation defects of sdh2Δ/Δ were rescued by decreasing intracellular ROS.

conclusionSDH2 plays an important role in C. albicans filamentation and virulence probably through affecting intracellular ROS. [Formula: see text].

Indexed as

AnimalsCaenorhabditis elegansCandida albicansCandidiasisColony Count, MicrobialDisease Models, AnimalFemaleFungal ProteinsHyphaeMiceMutationReactive Oxygen SpeciesSuccinate DehydrogenaseVirulenceFungal ProteinsReactive Oxygen SpeciesSuccinate DehydrogenaseCandida albicansmorphogenesissuccinate dehydrogenasevirulence

Identifiers

PMID30113213
PMCPMC6161146
OpenAlexW2886532330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.